首页> 中文期刊> 《临床医药实践》 >结直肠癌老年患者FOLFOX4全身化疗不同输液方式不良反应临床观察

结直肠癌老年患者FOLFOX4全身化疗不同输液方式不良反应临床观察

         

摘要

Objective:When the elderly patients with rectual cancer or conlon cancer were treated by FOLFOX4 chemo-therapy,to explore whether peripherally Inserted Central Catheters( PICC)is better than past infusion methods. Methods:All 163 patients cured by FOLFOX4 were divided into 3 groups with different infusion methods:PICC group,central venous cathe-terization( CVC)group,superficial vein detaining needle group. To observe the incidence of phlebitis,drug extravasation and pipes blockage after cured by FOLFOX4 for 2~4 weeks. Questionnaire survey to all patients whether quality of life was in-funced by the infusion method. Results:To compare other groups,the rates of phlebitis and drug extravasation were descented significantly(P﹤0. 05). All patients could accept the infusion method. Conclution:PICC was safer and accepted by patiants, could be extended in clinic.%目的:针对结直肠癌老年患者采用FOLFOX4方案全身化疗,探讨外周中心静脉置管术( PICC)较以往输液方式有无优势。方法:将163例老年结直肠癌患者随机分为PICC组、经锁骨下中心静脉置管术( CVC)组、浅静脉留置针组,采用FOLFOX4全身化疗2~4周期,观察静脉炎、药物外渗、导管堵塞发生率以及问卷调查输液方式对生活质量的影响。结果:与其他组比较,PICC组可明显减低静脉炎、药品外渗发生率,差异有统计学意义( P﹤0.05)。问卷调查显示,所有患者可接受此种输液方式。结论:PICC在老年结直肠患者FOLFOX4化疗中,安全性高,能为患者所接受。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号